Visit JCR Japan
Visit JCR Japan
Home
Who we are
Innovation
Pipeline
Patients & families
Our commitment
Partnerships
Investors & media
Our products
Contact us
jcalabro
Italfarmaco and JCR Pharmaceuticals announce commercialisation agreement for Givinostat in Japan and strategic collaboration in rare disease
by jcalabro
JCR Pharmaceuticals and Alexion achieve milestone in collaborative neurodegenerative disease program
by jcalabro
Notice of personnel change
by jcalabro
Privacy Preference Center
Privacy Preferences
